Opens in a new tab

Fully Licensed Colombian EU Export Cultivation & Processing Hub

Fully Licensed Colombian EU Export Cultivation & Processing Hub
Country
ColombiaColombia
Listing ID
L#20261067
Target Price
$7,000,000
Revenue
$12,500,000
EBITDA
$6,000,000

Description

Fully licensed, export-ready Colombian cultivation and processing platform with GACP certification, EU-GMP Part I approval, and established EU distribution access. Proven export execution with ~1 tonne already shipped into European medical markets; includes advanced processing infrastructure and PLC 2500 purification system.

Unbeatable Production Arbitrage

Ultra-Low Costs

All-in production costs of €0.30 per gram, with further downward pressure expected as the facility scales toward its 25+ tonne licensed capacity.

Elite Genetics

Proven high-THC cultivars (mid-20% THC) featuring advanced terpene profiles tailored for European and Australian markets.

Ideal Climate

Located in a premium microclimate with stable, predictable conditions enabling year-round cultivation.

Institutional-Grade Infrastructure & Scalability

Immediate Capacity

1.7 hectares of interconnected greenhouses currently producing 5.7 tonnes of dried flower annually.

Expansion Ready

Fully licensed 15-hectare site with capacity for 25+ tonnes, enabling significant scale-up with minimal additional capex.

Operational Autonomy

Dedicated on-site power substation with diesel backup and a 20,000 m³ rainwater reservoir supported by a sophisticated water treatment system.

Advanced Post-Harvest & Processing Technology

Dual-Track Facility

Separate buildings for GACP post-harvest and EU-GMP / TGA GMP-compliant processing.

Unique Technology Edge

Includes Colombia’s only PLC 2500 purification system and an X-ray sterilization unit required for the Australian market.

On-Site Laboratory

Fully equipped lab enabling real-time potency and purity testing to ensure pharmaceutical-grade standards.

Validated Global Export Track Record

Proven Market Access

One of the few Colombian producers with established exports; approximately 1 tonne already delivered to European markets.

De-Risked Revenue

Sale includes a binding 3-year offtake agreement and established distribution relationships in Germany and the UK.

Turnkey Transition & Strategic Value

  1. 01
    Investment ValueOver USD $12M already invested in infrastructure, licensing, and elite genetics.
  2. 02
    Financial StatusDebt-free; all related-party debt is forgiven at closing.
  3. 03
    Shortcut to MarketBypasses the typical 3-year development cycle including site selection, construction, and regulatory approvals in Colombia.
  4. 04
    Management ContinuityCore leadership team, including production specialists, will remain to ensure a seamless operational transition.
  5. 05
    Tax EfficiencyTax loss carryforwards (~USD $1.5M) available through 2036, preserved under the share sale structure.

Financial Forecast

Parameter / Metric Conservative Scenario Base Scenario Optimistic Scenario
Asking / Target Price TBD (On Request) TBD (On Request) TBD (On Request)
Annual Finished Extraction Capacity ~5,000 kg ~8,000 kg ~12,000 kg
Average Export Price / Gram (EU GMP) $2.50 / g $3.50 / g $4.50 / g
Estimated Gross Revenue ~$12,500,000 USD ~$28,000,000 USD ~$54,000,000 USD
Estimated Production & OPEX ~$6,500,000 USD ~$12,000,000 USD ~$21,000,000 USD
Estimated EBITDA ~$6,000,000 USD ~$16,000,000 USD ~$33,000,000 USD
EBITDA Margin ~48% ~57% ~61%

Basic Details

Listing ID
L#20261067
Country
Colombia
Industry
Manufacturing
Deal Status
Available
Target Price
$7,000,000
Revenue
$12,500,000
EBITDA
$6,000,000
Revenue Multiple
0.56x
EBITDA Multiple
1.17x

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000